Schroders PLC
11 March 2003
SCHRODERS PLC
In compliance with Section 329 of the Companies Act 1985 and Chapter 16,
paragraph 13 of the Listing Rules, we hereby notify you that on 10th March 2003
the following directors of Schroders plc were granted awards giving them the
right to acquire the numbers of non-voting ordinary shares in Schroders plc set
against their respective names under the Rules of the Company's Equity
Compensation Plan and the Share Option Plan
Equity Compensation Plan Option Plan
J.P. Asquith 133,969 100,000
M.W.R. Dobson 352,186 150,000
R.M.A. Horlick 334,924 200,000
A.F. Sykes 20,094 40,000
M. Tosato 80,381 65,000
The awards under the Equity Compensation Plan were granted for no consideration
and are not normally exercisable for three years. The options were granted at a
price of £3.98 per share and are not normally exercisable for three years and
then only if the applicable performance targets have been met.
J.P. Bainbridge
Company Secretary
11th March 2003
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.